Cytocom Inc. — Form D
Cytocom Inc. of Fort Collins, CO, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-13. The offering totals $6.0M. Industry: Biotechnology.
Offering
- Filed: 2021-01-13
- Form: D
- Accession: 0001192482-21-000055
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Remaining: $6.0M
- Investors: 6
- Revenue range: No Revenues
- SEC file number: 021-386114
Issuer
- Name: Cytocom Inc.
- CIK: 0001815773
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2537 Research Blvd, Suite 201, Fort Collins, CO, 80526
- Phone: 888-629-4155
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Noreen K Griffin | Director | Fort Collins, CO |
| Michael K Handley | Director | Fort Collins, CO |
| Taunia Markvicka | Director | Fort Collins, CO |
| Peter Aronstam | Executive Officer | Fort Collins, CO |
| Noreen K Griffin | Executive Officer | Fort Collins, CO |
| Michael K Handley | Executive Officer | Fort Collins, CO |
| Taunia Markvicka | Executive Officer | Fort Collins, CO |
| Cozette K McAvoy | Executive Officer | Fort Collins, CO |
| Clifford K Selsky | Executive Officer | Fort Collins, CO |
| Michael Handley | Director | Fremont, CA |
| Michael Handley | Executive Officer | Fremont, CA |
| Noreen McGurrin Griffin | Director | Winter Park, FL |
| Noreen McGurrin Griffin | Executive Officer | Winter Park, FL |
| Cozette McGurrin McAvoy | Executive Officer | Winter Park, FL |
Other filings by this issuer (1)
More